Sarissa Capital Hawkeye Fund LP's Net Worth

$50 Million

Estimate Recalculated May 21, 2024 03:28PM EST

Who is Sarissa Capital Hawkeye Fund LP?

Sarissa Capital Hawkeye Fund LP has an estimated net worth of $50 Million. This is based on reported shares across multiple companies, which include Iterum Therapeutics plc, and Regulus Therapeutics Inc..

SEC CIK

Sarissa Capital Hawkeye Fund LP's CIK is 0001777184

Past Insider Trading and Trends

2019 was Sarissa Capital Hawkeye Fund LP's most active year for acquiring shares with 2 total transactions. Sarissa Capital Hawkeye Fund LP's most active month to acquire stocks was the month of November. 2021 was Sarissa Capital Hawkeye Fund LP's most active year for disposing of shares, totalling 3 transactions. Sarissa Capital Hawkeye Fund LP's most active month to dispose stocks was the month of January. 2021 saw Sarissa Capital Hawkeye Fund LP paying a total of $0.00 for 20,619,949 shares, this is the most they've acquired in one year. In 2021 Sarissa Capital Hawkeye Fund LP cashed out on 35,619,949 shares for a total of $50,007,284.23, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Iterum Therapeutics plc (ITRM) Snapshot price: $1.7283

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$2.43
-$50,007,284.23
20.62M
Feb 11 - Feb 12
Form 3
—
0
—
—
0
No matching records found

Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.3973

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 24
Form 3
—
0
—
—
0
No matching records found